On the fly News and insights, exclusive to thefly.com

AZN

AstraZeneca

$37.15 /

-0.49 (-1.30%)

, BMY

Bristol Myers

$57.50 /

+ (+0.00%)

07:04
10/13/18
10/13
07:04
10/13/18
07:04

Week in review: How Trump's policies moved stocks

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump and his administration with this weekly recap compiled by The Fly: 1. FEDERAL RESERVE: President Trump once again criticized the Federal Reserve for lowering interest rates following a big market selloff, being quoted as stating, "The Fed has gone crazy" and that the central bank "is too tight." In an interview with Fox News on Wednesday night, Trump added that the Fed "is going loco and there is no reason for them to do it." 2. TRUMP-XI MEETING: U.S. President Donald Trump and Chinese President Xi Jinping have agreed to meet next month at the G-20 summit in Buenos Aires at the end of November to discuss the trade conflict that has grown more intense, according to The Washington Post, citing three people briefed on the arrangement. 3. DRUG PRICE TRANSPARENCY: President Donald Trump is set to sign two measures of legislation into law that are aiming to make drug prices more transparent, according to CNN. The Lowest Price Act and the Patient Right to Know Drug Prices Act "aim to end the drug industry's so-called gag orders of pharmacists, which prevent them from discussing cheaper price options with consumers," added CNN. Publicly traded drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). 4. NEW YORK TIMES: JPMorgan analyst Alexia Quadrani raised her price target on New York Times (NYT) shares earlier this week to $32 from $27, citing ongoing digital subscriber growth as the "Trump bump" continues. Looking at results for the second half of the year, Quadrani projects a ramp in digital subscriber growth in part driven by the Kavanaugh hearings, Trump tax stories, and midterm elections. Additionally, the analyst noted that she believes churn remains relatively low. Since taking office, President Donald Trump has been very critical of the New York Times and many of its media peers, frequently using the term "fake news" to deride their reporting. 5. USPS PRICE HIKE: Shares of Stamps.com (STMP) jumped on Thursday after the U.S. Postal Service proposed the biggest price jump on stamps in its history. Facing pressure from President Trump and his administration, USPS is looking to raise the price of 1-oz. letters to 55c from 50c. If approved by regulators, the Postal Service is said to plan to also increase the shipping service cost used by Amazon (AMZN) by 9%-12%, just months after President Donald Trump criticized USPS for giving too good of a deal to the e-commerce giant. "Week in Review" is The Fly's weekly recap of its recurring series of "Trump Effect" exclusive stories.

AZN

AstraZeneca

$37.15 /

-0.49 (-1.30%)

BMY

Bristol Myers

$57.50 /

+ (+0.00%)

LLY

Eli Lilly

$110.49 /

+2.54 (+2.35%)

GSK

GSK

$38.31 /

-0.17 (-0.44%)

JNJ

Johnson & Johnson

$133.78 /

-0.03 (-0.02%)

MRK

Merck

$69.77 /

+1.41 (+2.06%)

NVS

Novartis

$82.77 /

+0.56 (+0.68%)

PFE

Pfizer

$43.78 /

+0.97 (+2.27%)

RHHBY

Roche

$0.00 /

+ (+0.00%)

SNY

Sanofi

$42.89 /

-0.83 (-1.90%)

NYT

New York Times

$24.98 /

+0.145 (+0.58%)

STMP

Stamps.com

$214.32 /

-0.43 (-0.20%)

AMZN

Amazon.com

$1,788.63 /

+69.51 (+4.04%)

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 24

    Dec

  • 11

    Jan

  • 28

    Jan

  • 16

    Feb

  • 22

    Mar

  • 28

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.